The ‘Very, Very Bad Look’ of Remdesivir, the First FDA-approved COVID-19 Drug

October was a good month for Gilead Sciences, the giant manufacturer of antivirals headquartered in Foster City, California. On 8 October, the company inked an agreement to supply the European Union with its drug remdesivir as a treatment for COVID-19—a

The post The ‘Very, Very Bad Look’ of Remdesivir, the First FDA-approved COVID-19 Drug appeared first on Global Research.

October was a good month for Gilead Sciences, the giant manufacturer of antivirals headquartered in Foster City, California. On 8 October, the company inked an agreement to supply the European Union with its drug remdesivir as a treatment for COVID-19—a

The post The ‘Very, Very Bad Look’ of Remdesivir, the First FDA-approved COVID-19 Drug appeared first on Global Research.


Go to Source
Author: Jon Cohen

Comments